BELLEVUE GROUP AG – Sage Therapeutics, Inc. Transaction History
BELLEVUE GROUP AG portfolio value:
$116.33M
portfolio value
BELLEVUE GROUP AG quarter portfolio value change:
+21.24%
quarter
Sage Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.08% | -2.5K shares | 20.29M | $39.16 | 2.97M |
| Q2 2022 | share | Decrease | -2.60% | -79.22K shares | -5M | $32.3 | 2.97M |
| Q1 2022 | share | Decrease | -5.44% | -175.6K shares | -36.28M | $33.1 | 3.05M |
| Q4 2021 | share | Increase | +0.59% | 19K shares | -4.87M | $43.25 | 3.22M |
| Q3 2021 | share | Increase | +35.73% | 844.8K shares | 7.88M | $44.31 | 3.20M |
| Q2 2021 | share | Increase | +30.57% | 553.5K shares | -1.22M | $56.81 | 2.36M |
| Q1 2021 | share | Increase | +15.52% | 243.2K shares | -72K | $74.85 | 1.81M |
| Q4 2020 | share | Decrease | -0.76% | -12K shares | 39.06M | $86.51 | 1.56M |
| Q3 2020 | share | Increase | +11.59% | 164K shares | 37.68M | $61.12 | 1.57M |
| Q2 2020 | share | Decrease | -0.18% | -2.6K shares | 18.12M | $41.58 | 1.41M |
| Q1 2020 | share | Increase | +8.35% | 109.25K shares | -53.75M | $28.72 | 1.41M |
| Q4 2019 | share | Increase | +0.41% | 5.35K shares | -88.38M | $72.19 | 1.30M |
| Q3 2019 | share | Decrease | -1.35% | -17.9K shares | -59.06M | $140.29 | 1.30M |
| Q2 2019 | share | Increase | +8006.77% | 1.30M shares | 239.34M | $183.09 | 1.32M |
| Q1 2019 | share | Increase | +53.77% | 5.7K shares | 1.57M | $159.05 | 16.3K |
| Q4 2018 | share | Decrease | -5.36% | -600 shares | -567K | $95.79 | 10.6K |
| Q3 2018 | share | Decrease | -7.44% | -900 shares | -312K | $141.25 | 11.2K |
| Q2 2018 | share | Decrease | -2.81% | -350 shares | -111K | $156.53 | 12.1K |
| Q1 2018 | share | Decrease | -1.58% | -200 shares | -79K | $161.07 | 12.45K |
| Q4 2017 | share | Increase | 0.00% | 12.65K shares | 2.08M | $164.71 | 12.65K |